| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/20/2013 | CN101312736B Encapsulation system |
| 03/20/2013 | CN101277683B Retard formulation for pralnacasan |
| 03/20/2013 | CN101277681B Oral solid pharmaceutical formulation of the tribulin inhibitor indibulin |
| 03/19/2013 | US8399751 Functional abiotic nanosystems |
| 03/19/2013 | US8399732 Adhesive patch |
| 03/19/2013 | US8399496 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 03/19/2013 | US8399469 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/19/2013 | US8399466 Composition for regenerative treatment of cartilage disease |
| 03/19/2013 | US8399446 Methods of treating hypertriglyceridemia |
| 03/19/2013 | US8399432 Compositions and methods of treatment for alleviating premenstrual syndrome symptoms |
| 03/19/2013 | US8399414 Analgesics |
| 03/19/2013 | US8399410 Methods and devices for desmopressin drug delivery |
| 03/19/2013 | US8399399 compared with their structural isomer 2-methyl-4-dodecanal, are characterized by an odor threshold concentration which is up to 64 times lower |
| 03/19/2013 | US8399044 Method for coating medication on medical article |
| 03/19/2013 | US8399024 Water-insoluble medicine |
| 03/19/2013 | US8399023 Crystallization method and bioavailability |
| 03/19/2013 | US8399022 Spherical ferrite nanoparticles and method for producing the same |
| 03/19/2013 | US8399021 Preparation of poly(ethylene oxide)-coated nanoparticles of maghemite |
| 03/19/2013 | US8399020 Shaped plant growth nutrient products and processes for the production thereof |
| 03/19/2013 | US8399019 Oral delivery vehicle and material |
| 03/19/2013 | US8399018 Controlled release ion channel modulator compositions and methods for the treatment of otic disorders |
| 03/19/2013 | US8399017 Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix |
| 03/19/2013 | US8399016 Sustained-release tablet composition of pramipexole |
| 03/19/2013 | US8399015 Solid pharmaceutical dosage form |
| 03/19/2013 | US8399011 Oral particle compositions containing a core and an acid-soluble coat |
| 03/19/2013 | US8399009 Bioceramic and biopolymer composite |
| 03/19/2013 | US8399003 Formulations and methods employing anhydrous disinfectant |
| 03/19/2013 | US8398998 Therapeutic composition comprising a botulinum neurotoxin |
| 03/19/2013 | US8398984 Removal promoters and inhibitor for apoptosis cells in vivo |
| 03/19/2013 | US8398967 Particle formulations for use in pharmaceutical compositions |
| 03/19/2013 | US8398957 Aerosol compositions |
| 03/19/2013 | US8398617 Tools and methods for programming an implantable valve |
| 03/19/2013 | US8398616 Safety layer for integrated insulin delivery system |
| 03/19/2013 | CA2640339C Tamper resistant opioid dosage forms |
| 03/19/2013 | CA2603817C Compositions containing micronized tanaproget prepared by wet granulation |
| 03/19/2013 | CA2603806C Micronized tanaproget, compositions, and methods of preparing the same |
| 03/19/2013 | CA2578534C Transdermal therapeutic system comprising an adhesive layer, method of siliconizing the back layer of the system and use of said back layer |
| 03/19/2013 | CA2568378C Formulation obtained from a powder mixture comprising an inorganic pigment |
| 03/19/2013 | CA2549041C Consumer customized dosage forms |
| 03/19/2013 | CA2537178C Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer |
| 03/19/2013 | CA2534313C Formulations containing an immune response modifier |
| 03/19/2013 | CA2499278C Method of preparing dry powder inhalation compositions |
| 03/19/2013 | CA2488499C Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions |
| 03/14/2013 | WO2013036974A1 Cellular uptake control systems |
| 03/14/2013 | WO2013036934A1 Antioxidant formulations |
| 03/14/2013 | WO2013036931A1 Targeted liposomes in cancer therapy |
| 03/14/2013 | WO2013036914A1 Materials and methods for modulating immune responses |
| 03/14/2013 | WO2013036844A2 Methods for treatment of and prophylaxis against hemorrhoids |
| 03/14/2013 | WO2013036775A1 Silicone coated implants |
| 03/14/2013 | WO2013036568A1 Hyaluronic acid/collagen- based dermal filler compositions and methods for making same |
| 03/14/2013 | WO2013036563A1 Pharmaceutical compositions comprising an aromatase inhibitor |
| 03/14/2013 | WO2013036562A1 Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases |
| 03/14/2013 | WO2013036532A1 Amphipathic co-oligomers for the delivery of sirna |
| 03/14/2013 | WO2013036383A1 Oral delivery for hemoglobin based oxygen carriers |
| 03/14/2013 | WO2013036296A1 Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers |
| 03/14/2013 | WO2013036115A1 Process to coat an active agent to a surface |
| 03/14/2013 | WO2013036072A1 Injectable therapeutic agent for arthritis |
| 03/14/2013 | WO2013035850A1 Transdermal preparation |
| 03/14/2013 | WO2013035837A1 Method for suppressing decrease in viscosity of aqueous liquid agent |
| 03/14/2013 | WO2013035757A1 Preparation comprising hexose-6-phosphate-modified cholesterol derivative |
| 03/14/2013 | WO2013035641A1 Method for manufacturing block copolymer |
| 03/14/2013 | WO2013035579A1 Liver-accumulative nanoparticle having drug encapsulated therein |
| 03/14/2013 | WO2013035113A1 Coated suppositories |
| 03/14/2013 | WO2013035072A1 Bioactive nanofibres |
| 03/14/2013 | WO2013034931A1 Oral suspension |
| 03/14/2013 | WO2013034927A1 Compositions of lopinavir and ritonavir |
| 03/14/2013 | WO2013034926A1 Compositions of lopinavir |
| 03/14/2013 | WO2013034925A1 Compositions of efavirenz |
| 03/14/2013 | WO2013034910A1 Inhalable compositions |
| 03/14/2013 | WO2013034909A1 Treating cough and tussive attacks |
| 03/14/2013 | WO2013034550A1 Pramipexole extended release tablets |
| 03/14/2013 | WO2013034436A1 Pharmaceutical composition for oral administration with a statin |
| 03/14/2013 | WO2013034267A1 Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof |
| 03/14/2013 | WO2013034174A1 Solid preparations of pioglitazone and glimepiride |
| 03/14/2013 | WO2013034173A1 Pramipexole extended release tablets |
| 03/14/2013 | WO2013034040A1 Celecoxib solid dispersion and preparation method therefor |
| 03/14/2013 | WO2013033838A1 Liposomal formulations of cationic peptides and uses thereof |
| 03/14/2013 | WO2013033815A1 Cellulosic gel material as a pharmaceutical excipient |
| 03/14/2013 | WO2012170334A3 Dressings and related methods therefor |
| 03/14/2013 | WO2012149393A3 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells |
| 03/14/2013 | WO2012149282A3 Tolerogenic synthetic nanocarriers for generating cd8+regulatory t cells |
| 03/14/2013 | WO2012149252A3 Tolerogenic synthetic nanocarriers |
| 03/14/2013 | WO2012115771A3 Systems and methods for therapy of kidney disease and/or heart failure using chimeric natriuretic peptides |
| 03/14/2013 | WO2012104655A3 Compostions and methods for treating chronic inflammation and inflammatory diseases |
| 03/14/2013 | WO2012101524A3 Radiopaque embolic particles |
| 03/14/2013 | WO2012061815A3 RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPs) |
| 03/14/2013 | WO2012044671A3 Method for removing residual organic solvent from microparticles |
| 03/14/2013 | US20130065885 Oral therapeutic compound delivery system |
| 03/14/2013 | US20130065869 Ophthalmologic irrigation solutions and method |
| 03/14/2013 | US20130064965 Implants for administering substances and methods of producing implants |
| 03/14/2013 | US20130064897 New process for producing hydrodispexible dry pharmaceutical composition and the pharmaceutical compositions thus obtained |
| 03/14/2013 | US20130064896 Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic Polymer |
| 03/14/2013 | US20130064895 Amphiphilic Peptides and Peptide Particles |
| 03/14/2013 | US20130064894 Novel cationic lipids and methods of use thereof |
| 03/14/2013 | US20130064893 Stabilized pharmaceutical composition |
| 03/14/2013 | US20130064892 Cellulosic gel material as a pharmaceutical excipient |
| 03/14/2013 | US20130064891 Pharmaceutical compositions of nsaid and acid inhibitor |
| 03/14/2013 | US20130064890 Pharmaceutical formulation based on ibuprofen and codeine having improved stability |
| 03/14/2013 | US20130064889 Tablet-in-tablet Palperidone Formulations and Methods for Production and Use Thereof |
| 03/14/2013 | US20130064888 Pharmaceutical formulations |